FOCUS ISSUE: ATRIAL FIBRILLATION: CLINICAL RESEARCH: STATINS AND ATRIAL FIBRILLATION
Antiarrhythmic Effect of Statin Therapy and Atrial FibrillationA Meta-Analysis of Randomized Controlled Trials
Laurent Fauchier, MD, PhD*,
Bertrand Pierre, MD,
Axel de Labriolle, MD,
Caroline Grimard, MD,
Noura Zannad, MD and
Dominique Babuty, MD, PhD
Cardiologie, Centre Hospitalier Universitaire Trousseau, Tours, France.
Manuscript received August 17, 2007;
accepted September 19, 2007.
* Reprint requests and correspondence: Dr. Laurent Fauchier, Service de Cardiologie B et Laboratoire dElectrophysiologie Cardiaque, Pole Cœur Thorax Vasculaire Hémostase, Centre Hospitalier Universitaire Trousseau, 37044 Tours, France. (Email: lfau{at}med.univ-tours.fr).
Objectives: To improve the evaluation of the possible antiarrhythmic effect of statins, we performed a meta-analysis of randomized trials with statins on the end point of incidence or recurrence of atrial fibrillation (AF).
Background: The use of statins had been suggested to protect against AF in some clinical observational and experimental studies but has remained inadequately explored.
Methods: A systematic review of controlled trials with statins was performed. Eligible studies had to have been randomized controlled parallel-design human trials with use of statins that collected data on incidence or recurrence of AF.
Results: Six studies with 3,557 patients in sinus rhythm were included in the analysis. Three studies investigated the use of statins in patients with a history of paroxysmal AF (n = 1) or persistent AF undergoing electrical cardioversion (n = 2), and 3 investigated the use of statins in primary prevention of AF in patients undergoing cardiac surgery or after acute coronary syndrome. Incidence or recurrence of AF occurred in 386 patients. Overall, the use of statins was significantly associated with a decreased risk of AF compared with control (odds ratio [OR] 0.39, 95% confidence interval [CI] 0.18 to 0.85, p = 0.02). Benefit of statin therapy seemed more marked in secondary prevention of AF (OR 0.33, 95% CI 0.10 to 1.03, p = 0.06) than for new-onset or postoperative AF (OR 0.60, 95% CI 0.27 to 1.37, p = 0.23).
Conclusions: Use of statins was significantly associated with a decreased risk of incidence or recurrence of AF in patients in sinus rhythm with a history of previous AF or undergoing cardiac surgery or after acute coronary syndrome.
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CI = confidence interval | | CRP = C-reactive protein | | LDL = low-density lipoprotein | | OR = odds ratio |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A23-A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
L. J. Haywood, C. E. Ford, R. S. Crow, B. R. Davis, B. M. Massie, P. T. Einhorn, A. Williard, and for the ALLHAT Collaborative Research Group
Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
2023 - 2031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Mason and J. P. DiMarco
New Pharmacological Agents for Arrhythmias
Circ Arrhythm Electrophysiol,
October 1, 2009;
2(5):
588 - 597.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Maggioni, G. Fabbri, D. Lucci, R. Marchioli, M. G. Franzosi, R. Latini, G. L. Nicolosi, M. Porcu, F. Cosmi, S. Stefanelli, et al.
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
Eur. Heart J.,
October 1, 2009;
30(19):
2327 - 2336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J.G.M. Crijns
Primary prevention of atrial fibrillation by statins: still unresolved?
Eur. Heart J.,
October 1, 2009;
30(19):
2302 - 2303.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. J. Liakopoulos, Y.-H. Choi, E. W. Kuhn, T. Wittwer, M. Borys, N. Madershahian, G. Wassmer, and T. Wahlers
Statins for prevention of atrial fibrillation after cardiac surgery: A systematic literature review
J. Thorac. Cardiovasc. Surg.,
September 1, 2009;
138(3):
678 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. L. S. Brookes, C. C. McGown, and C. S. Reilly
Statins for all: the new premed?
Br. J. Anaesth.,
July 1, 2009;
103(1):
99 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Europace,
July 1, 2009;
11(7):
860 - 885.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Anter, M. Jessup, and D. J. Callans
Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Circulation,
May 12, 2009;
119(18):
2516 - 2525.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C N Pellegrini, E Vittinghoff, F Lin, S B Hulley, and G M Marcus
Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial
Heart,
May 1, 2009;
95(9):
704 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Almroth, N. Hoglund, K. Boman, A. Englund, S. Jensen, B. Kjellman, P. Tornvall, and M. Rosenqvist
Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study
Eur. Heart J.,
April 1, 2009;
30(7):
827 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Balasubramaniam and P M Kistler
Atrial fibrillation in heart failure: the chicken or the egg?
Heart,
April 1, 2009;
95(7):
535 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al.
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Circulation,
February 3, 2009;
119(4):
606 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Eur. Heart J.,
February 2, 2009;
30(4):
410 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bajpai, I. Savelieva, and A. J. Camm
Treatment of atrial fibrillation
Br. Med. Bull.,
December 5, 2008;
(2008)
ldn046v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dorian and B. N. Singh
Upstream therapies to prevent atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2008;
10(suppl_H):
H11 - H31.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|